From: Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study
Group | UA (μmol/L) | ALB (g/L) | TBIL (μmol/L) |
---|---|---|---|
SCZ-AS(n = 107) | 308.29 ± 78.71a* | 42.79 ± 3.55a*** | 18.43 ± 9.00a*** |
 Male(n = 40) | 350.45 ± 66.54 | 44.02 ± 3.36a*** | 19.74 ± 10.89 a*** |
 Female(n = 67) | 284.72 ± 75.45 a** | 42.05 ± 3.48 a*** | 17.65 ± 7.65 a*** |
AU(n = 56) | 330.32 ± 81.69 a***,b** | 43.13 ± 3.17a*** | 16.56 ± 5.37a***,b** |
ANF(n = 51) | 286.19 ± 68.94 | 42.40 ± 3.92 a*** | 20.47 ± 11.49 a*** |
HC(n = 273) | 283.41 ± 68.61 | 48.01 ± 3.28 | 10.87 ± 5.18 |
 Male(n = 93) | 338.69 ± 52.42 | 48.93 ± 4.29 | 12.97 ± 6.24 |
 Female(n = 180) | 254.84 ± 57.72 | 47.54 ± 2.49 | 9.78 ± 4.16 |